These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16392812)

  • 1. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists.
    Jeong LS; Lee HW; Kim HO; Tosh DK; Pal S; Choi WJ; Gao ZG; Patel AR; Williams W; Jacobson KA; Kim HD
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1612-6. PubMed ID: 18255292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
    Choi WJ; Lee HW; Kim HO; Chinn M; Gao ZG; Patel A; Jacobson KA; Moon HR; Jung YH; Jeong LS
    Bioorg Med Chem; 2009 Dec; 17(23):8003-11. PubMed ID: 19879151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.
    Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA
    Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
    Kim HO; Ji XD; Siddiqi SM; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1994 Oct; 37(21):3614-21. PubMed ID: 7932588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
    Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
    J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2-chloro-N6-substituted-4'-thioadenosine-5'-N, N-dialkyluronamides as potent and selective A3 adenosine receptor antagonists.
    Choi WJ; Lee HW; Hou X; Kim HO; Jacobson KA; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):645-6. PubMed ID: 18776545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
    Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
    J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
    Gao ZG; Blaustein JB; Gross AS; Melman N; Jacobson KA
    Biochem Pharmacol; 2003 May; 65(10):1675-84. PubMed ID: 12754103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
    Gallo-Rodriguez C; Ji XD; Melman N; Siegman BD; Sanders LH; Orlina J; Fischer B; Pu Q; Olah ME; van Galen PJ
    J Med Chem; 1994 Mar; 37(5):636-46. PubMed ID: 8126704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-4'-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor.
    Lee HW; Shin DH; Jeong JY; Kim HO; Chun MW; Melman N; Gao ZG; Jacobson KA; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):607-9. PubMed ID: 16247997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of potent and selective human A3 adenosine receptor agonists.
    Jeong LS; Lee HW; Jacobson KA; Lee SK; Chun MW
    Nucleic Acids Symp Ser (Oxf); 2005; (49):31-2. PubMed ID: 17150618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors.
    Baraldi PG; Cacciari B; Spalluto G; Ji XD; Olah ME; Stiles G; Dionisotti S; Zocchi C; Ongini E; Jacobson KA
    J Med Chem; 1996 Feb; 39(3):802-6. PubMed ID: 8576924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
    Siddiqi SM; Jacobson KA; Esker JL; Olah ME; Ji XD; Melman N; Tiwari KN; Secrist JA; Schneller SW; Cristalli G
    J Med Chem; 1995 Mar; 38(7):1174-88. PubMed ID: 7707320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
    Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR
    J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.